Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Brandwein

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|March 9, 2023
A phase IV study evaluating QT interval, pharmacokinetics, and safety following fractionated dosing of gemtuzumab ozogamicin in patients with relapsed/refractory CD33-positive acute myeloid leukemiaPau Montesinos, Vamsi Kota, Joseph Brandwein, et al.
International Journal of Molecular Sciences|January 11, 2024
An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 ReporterJustine Lai, Chuquan Shang, Will Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cellsPaul Chen, Judy Wang, Kristin Hope, et al.
Leukemia Research|November 16, 2004
Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL)Vikas Gupta, Qi-long Yi, Joseph Brandwein, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 9, 2016
Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemiaBreanne Landry, Hilal Gül-Uludağ, Samarwadee Plianwong, et al.
Leukemia & Lymphoma|October 18, 2012
Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort studyBrian J Minnema, Shahid Husain, Tony Mazzulli, et al.
ACS Pharmacology & Translational Science|September 19, 2024
Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic LeukemiaMohammad Nasrullah, Remant Kc, Kyle Nickel, et al.
Advanced Healthcare Materials|July 21, 2025
Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic DeliveryMohammad Nasrullah, Remant Kc, Amarnath Praphakar Rajendran, et al.
Psycho-Oncology|November 15, 2011
Traumatic stress in acute leukemiaGary Rodin, Dora Yuen, Ashley Mischitelle, et al.
Bone Marrow Transplantation|August 16, 2018
Anti-thymocyte globulin's activity against acute myeloid leukemia stem cellsRosy Dabas, Poonam Dharmani-Khan, Monica Modi, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|March 9, 2023
A phase IV study evaluating QT interval, pharmacokinetics, and safety following fractionated dosing of gemtuzumab ozogamicin in patients with relapsed/refractory CD33-positive acute myeloid leukemiaPau Montesinos, Vamsi Kota, Joseph Brandwein, et al.
International Journal of Molecular Sciences|January 11, 2024
An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 ReporterJustine Lai, Chuquan Shang, Will Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cellsPaul Chen, Judy Wang, Kristin Hope, et al.
Leukemia Research|November 16, 2004
Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL)Vikas Gupta, Qi-long Yi, Joseph Brandwein, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 9, 2016
Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemiaBreanne Landry, Hilal Gül-Uludağ, Samarwadee Plianwong, et al.
Leukemia & Lymphoma|October 18, 2012
Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort studyBrian J Minnema, Shahid Husain, Tony Mazzulli, et al.
ACS Pharmacology & Translational Science|September 19, 2024
Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic LeukemiaMohammad Nasrullah, Remant Kc, Kyle Nickel, et al.
Advanced Healthcare Materials|July 21, 2025
Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic DeliveryMohammad Nasrullah, Remant Kc, Amarnath Praphakar Rajendran, et al.
Psycho-Oncology|November 15, 2011
Traumatic stress in acute leukemiaGary Rodin, Dora Yuen, Ashley Mischitelle, et al.
Bone Marrow Transplantation|August 16, 2018
Anti-thymocyte globulin's activity against acute myeloid leukemia stem cellsRosy Dabas, Poonam Dharmani-Khan, Monica Modi, et al.
Pageof 8